vs
Pediatrix Medical Group, Inc.（MD）与医疗房产信托（SVC）财务数据对比。点击上方公司名可切换其他公司
Pediatrix Medical Group, Inc.的季度营收约是医疗房产信托的1.7倍（$493.8M vs $296.5M），Pediatrix Medical Group, Inc.净利率更高（6.8% vs -0.3%，领先7.1%），Pediatrix Medical Group, Inc.同比增速更快（-1.7% vs -17.0%），过去两年Pediatrix Medical Group, Inc.的营收复合增速更高（-0.1% vs -6.1%）
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
医疗房产信托（MPT）是总部位于阿拉巴马州伯明翰的国际房地产投资信托（REIT），主要在美国和欧洲地区收购投资医疗设施与营利性医疗控股公司。该公司的房产收购多采用售后回租模式，原产权方出售房产给MPT后成为承租租户，其租户普遍签订长期三净租约。
MD vs SVC — 直观对比
营收规模更大
MD
是对方的1.7倍
$296.5M
营收增速更快
MD
高出15.3%
-17.0%
净利率更高
MD
高出7.1%
-0.3%
两年增速更快
MD
近两年复合增速
-6.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $493.8M | $296.5M |
| 净利润 | $33.7M | $-782.0K |
| 毛利率 | — | — |
| 营业利润率 | 9.9% | -3.9% |
| 净利率 | 6.8% | -0.3% |
| 营收同比 | -1.7% | -17.0% |
| 净利润同比 | 10.5% | 99.0% |
| 每股收益（稀释后） | $0.40 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDSVC
| Q4 25 | $493.8M | $296.5M | ||
| Q3 25 | $492.9M | $377.6M | ||
| Q2 25 | $468.8M | $404.4M | ||
| Q1 25 | $458.4M | $335.0M | ||
| Q4 24 | $502.4M | $357.0M | ||
| Q3 24 | $511.2M | $390.9M | ||
| Q2 24 | $504.3M | $412.5M | ||
| Q1 24 | $495.1M | $336.2M |
净利润MDSVC
| Q4 25 | $33.7M | $-782.0K | ||
| Q3 25 | $71.7M | $-46.9M | ||
| Q2 25 | $39.3M | $-38.2M | ||
| Q1 25 | $20.7M | $-116.4M | ||
| Q4 24 | $30.5M | $-76.4M | ||
| Q3 24 | $19.4M | $-46.9M | ||
| Q2 24 | $-153.0M | $-73.8M | ||
| Q1 24 | $4.0M | $-78.4M |
营业利润率MDSVC
| Q4 25 | 9.9% | -3.9% | ||
| Q3 25 | 13.8% | -12.8% | ||
| Q2 25 | 12.8% | -9.2% | ||
| Q1 25 | 7.0% | -33.3% | ||
| Q4 24 | 7.8% | -19.4% | ||
| Q3 24 | 6.6% | -12.8% | ||
| Q2 24 | -31.3% | -17.1% | ||
| Q1 24 | 3.2% | -21.4% |
净利率MDSVC
| Q4 25 | 6.8% | -0.3% | ||
| Q3 25 | 14.5% | -12.4% | ||
| Q2 25 | 8.4% | -9.4% | ||
| Q1 25 | 4.5% | -34.8% | ||
| Q4 24 | 6.1% | -21.4% | ||
| Q3 24 | 3.8% | -12.0% | ||
| Q2 24 | -30.3% | -17.9% | ||
| Q1 24 | 0.8% | -23.3% |
每股收益（稀释后）MDSVC
| Q4 25 | $0.40 | $-0.01 | ||
| Q3 25 | $0.84 | $-0.28 | ||
| Q2 25 | $0.46 | $-0.23 | ||
| Q1 25 | $0.24 | $-0.70 | ||
| Q4 24 | $0.37 | $-0.46 | ||
| Q3 24 | $0.23 | $-0.28 | ||
| Q2 24 | $-1.84 | $-0.45 | ||
| Q1 24 | $0.05 | $-0.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $375.2M | $346.8M |
| 总债务越低越好 | $570.5M | $5.5B |
| 股东权益账面价值 | $865.9M | $646.1M |
| 总资产 | $2.2B | $6.5B |
| 负债/权益比越低杠杆越低 | 0.66× | 8.52× |
8季度趋势，按日历期对齐
现金及短期投资MDSVC
| Q4 25 | $375.2M | $346.8M | ||
| Q3 25 | $340.1M | $417.4M | ||
| Q2 25 | $224.7M | $63.2M | ||
| Q1 25 | $99.0M | $80.1M | ||
| Q4 24 | $229.9M | $143.5M | ||
| Q3 24 | $103.8M | $48.6M | ||
| Q2 24 | $19.4M | $14.6M | ||
| Q1 24 | $8.0M | $71.3M |
总债务MDSVC
| Q4 25 | $570.5M | $5.5B | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | $5.8B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MDSVC
| Q4 25 | $865.9M | $646.1M | ||
| Q3 25 | $890.7M | $647.9M | ||
| Q2 25 | $833.8M | $695.9M | ||
| Q1 25 | $789.2M | $734.6M | ||
| Q4 24 | $764.9M | $851.9M | ||
| Q3 24 | $732.5M | $929.0M | ||
| Q2 24 | $706.5M | $1.0B | ||
| Q1 24 | $856.2M | $1.1B |
总资产MDSVC
| Q4 25 | $2.2B | $6.5B | ||
| Q3 25 | $2.2B | $7.0B | ||
| Q2 25 | $2.1B | $6.9B | ||
| Q1 25 | $2.0B | $7.0B | ||
| Q4 24 | $2.2B | $7.1B | ||
| Q3 24 | $2.1B | $7.1B | ||
| Q2 24 | $2.0B | $7.1B | ||
| Q1 24 | $2.2B | $7.2B |
负债/权益比MDSVC
| Q4 25 | 0.66× | 8.52× | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | 6.85× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $114.1M | $-18.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-95.2M |
| 自由现金流率自由现金流/营收 | — | -32.1% |
| 资本支出强度资本支出/营收 | — | 25.9% |
| 现金转化率经营现金流/净利润 | 3.39× | — |
| 过去12个月自由现金流最近4个季度 | — | $-107.0M |
8季度趋势，按日历期对齐
经营现金流MDSVC
| Q4 25 | $114.1M | $-18.5M | ||
| Q3 25 | $137.3M | $98.1M | ||
| Q2 25 | $137.2M | $-7.0K | ||
| Q1 25 | $-117.5M | $38.2M | ||
| Q4 24 | $133.0M | $-9.7M | ||
| Q3 24 | $91.8M | $106.2M | ||
| Q2 24 | $107.0M | $43.8M | ||
| Q1 24 | $-125.2M | $-926.0K |
自由现金流MDSVC
| Q4 25 | — | $-95.2M | ||
| Q3 25 | — | $57.9M | ||
| Q2 25 | — | $-46.6M | ||
| Q1 25 | — | $-23.2M | ||
| Q4 24 | — | $-88.9M | ||
| Q3 24 | — | $24.1M | ||
| Q2 24 | — | $-22.3M | ||
| Q1 24 | — | $-77.2M |
自由现金流率MDSVC
| Q4 25 | — | -32.1% | ||
| Q3 25 | — | 15.3% | ||
| Q2 25 | — | -11.5% | ||
| Q1 25 | — | -6.9% | ||
| Q4 24 | — | -24.9% | ||
| Q3 24 | — | 6.2% | ||
| Q2 24 | — | -5.4% | ||
| Q1 24 | — | -23.0% |
资本支出强度MDSVC
| Q4 25 | — | 25.9% | ||
| Q3 25 | — | 10.6% | ||
| Q2 25 | — | 11.5% | ||
| Q1 25 | — | 18.3% | ||
| Q4 24 | — | 22.2% | ||
| Q3 24 | — | 21.0% | ||
| Q2 24 | — | 16.0% | ||
| Q1 24 | — | 22.7% |
现金转化率MDSVC
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -31.03× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
SVC
暂无分部数据
